Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia

This publication has 15 references indexed in Scilit:

• Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism
  Clinical Pharmacology & Therapeutics, 1989
• ARE CHILDREN WITH LYMPHOBLASTIC LEUKAEMIA GIVEN ENOUGH 6-MERCAPTOPURINE?
  The Lancet, 1987
• Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations
  Clinical Pharmacology & Therapeutics, 1987
• Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells
  Journal of Chromatography B: Biomedical Sciences and Applications, 1987
• Oral 6-mercaptopurine in childhood leukemia: Parent drug pharmacokinetics and active metabolite concentrations
  Clinical Pharmacology & Therapeutics, 1986
• Acute Lymphoblastic Leukemia in Childhood
  Pediatric Clinics of North America, 1985
• Childhood leukaemia: a relationship between intracellular 6‐ mercaptopurine metabolites and neutropenia.
  British Journal of Clinical Pharmacology, 1983
• Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine, in human red blood cells
  Journal of Pharmacy and Pharmacology, 1983
• Thiopurine methyltransferase biochemical genetics: Human lymphocyte activity
  Biochemical Genetics, 1982
• Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical properties
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1978